• 제목/요약/키워드: Neoplasms

검색결과 2,382건 처리시간 0.027초

A Retrospective Clinical View of Basal Cell Carcinoma and Squamous Cell Carcinoma in the Head and Neck Region: A Single Institution's Experience of 247 Cases over 19 Years

  • Kang, Kyung Won;Lee, Dong Lark;Shin, Hea Kyeong;Jung, Gyu Yong;Lee, Joon Ho;Jeon, Myeong Su
    • 대한두개안면성형외과학회지
    • /
    • 제17권2호
    • /
    • pp.56-62
    • /
    • 2016
  • Background: The two most common skin cancers are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The purpose of this study was to describe the detailed clinical behavior of BCC and SCC in the head and neck region over 19 years at a single institution. Methods: A retrospective analysis was performed for all patients with non-melanoma skin cancer who had undergone surgical resection over an 18-year period. Patient charts were reviewed for demographic information, tumor size, onset-to-diagnosis, anatomic location, clinical subtype, histologic differentiation, method of surgical treatment, and recurrence. Results: The review identified 265 cases of either BCC or SCC in 226 patients. Of the 226 patients, 80 (35.4%) were men and 146 (64.6%) were women. BCC (n=138, 55.9%) was more frequent than SCC (109, 44.1%). The most frequent age group was 70-to-79 year olds (45 patients, 35.2%) for BCC and 80-to-89 year olds (41 patients, 41.8%) for SCC. By aesthetic units of the face, the most common location was the nasal unit (44 cases, 31.9%) for BCC and the buccal unit (23 cases, 21.1%) for SCC. The most common clinical subtype of BCC was the nodular type (80 cases, 58.0%). Local flaps were most commonly used to cover surgical defects (136 cases, 55.1%). Recurrent rates were 2.2% for BCC and 5.5% for SCC. Conclusion: In our study, many characteristics of BCC and SCC were compared to previously published reports were generally similar, except the ratio of BCC to SCC. Further study can help to establish the characteristics of BCC and SCC.

MicroRNA-23a: A Novel Serum Based Diagnostic Biomarker for Lung Adenocarcinoma

  • Lee, Yu-Mi;Cho, Hyun-Jung;Lee, Soo-Young;Yun, Seong-Cheol;Kim, Ji-Hye;Lee, Shin-Yup;Kwon, Sun-Jung;Choi, Eu-Gene;Na, Moon-Jun;Kang, Jae-Ku;Son, Ji-Woong
    • Tuberculosis and Respiratory Diseases
    • /
    • 제71권1호
    • /
    • pp.8-14
    • /
    • 2011
  • Background: MicroRNAs (miRNAs) have demonstrated their potential as biomarkers for lung cancer diagnosis. In recent years, miRNAs have been found in body fluids such as serum, plasma, urine and saliva. Circulating miRNAs are highly stable and resistant to RNase activity along with, extreme pH and temperatures in serum and plasma. In this study, we investigated serum miRNA profiles that can be used as a diagnostic biomarker of non-small cell lung cancer (NSCLC). Methods: We compared the expression profile of miRNAs in the plasma of patients diagnosed with lung cancer using an miRNA microarray. The data from this assay were validated by quantitative real-time PCR (qRT-PCR). Results: Six miRNAs were overexpressed and three miRNAs were underexpressed in both tissue and serum from squamous cell carcinoma (SCC) patients. Sixteen miRNAs were overexpressed and twenty two miRNAs were underexpressed in both tissue and serum from adenocarcinoma (AC) patients. Of the four miRNAs chosen for qRT-PCR analysis, the expression of miR-23a was consistent with microarray results from AC patients. Receiver operating characteristic (ROC) curve analyses were done and revealed that the level of serum miR-23a was a potential marker for discriminating AC patients from chronic obstructive pulmonary disease (COPD) patients. Conclusion: Although a small number of patients were examined, the results from our study suggest that serum miR-23a can be used in the diagnosis of AC.

NCCN 암성 통증 가이드라인에 따른 폐암 환자의 암성 통증 조절 (Pain Management Based on NCCN Guideline in Patients with Lung Cancer)

  • 김현태;고경원;김여명;강민수;노희선;김혜련;김철현;이재철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제67권3호
    • /
    • pp.221-225
    • /
    • 2009
  • Background: Pain is one of the most troublesome problems caused by malignancy. We evaluated the change in pain status according to observance of NCCN guidelines in lung cancer patients. Methods: Lung cancer patients complaining of pain at admission were examined. The pain was assessed with visual analogue scale (VAS) for 20 days and moderate-to-severe pain was defined as more than VAS level 3. The guideline observance was classified as high (more than 80%), medium (50~79%) and low (less than 50%). Results: Among the total 91 lung cancer patients with pain, 34 patients (37%) had moderate-to-severe pain. Their average VAS score at admission was 5.6. It decreased to 2.9 after a 20-day period of pain management. The time to reach a VAS less than 3 was 3 days in a high guideline observance group, while it took 6 days in a low observance group. In addition, the pain in the high observance group was controlled to less than 3 VAS level in 86% of patients, whereas only 25% of patients in the low observance group succeeded. Conclusion: Pain was more effectively controlled when the dose of drugs was modified according to NCCN guidelines in lung cancer patients indicating the importance of guideline observance in pain management.

부산시 일개구 지역주민의 위암선별검사 수검 및 반복수검 실태 및 관련요인조사 (Stomach Cancer Screening and Repeat Screening Behaviors among Adults in an Urban Area)

  • 정인숙;배은숙;천동환;전진호;이화자;박남희
    • 보건교육건강증진학회지
    • /
    • 제20권1호
    • /
    • pp.91-109
    • /
    • 2003
  • The importance of repeat screening for stomach cancer is well known to decrease deaths from stomach cancer. This study was aimed at assessing practice behaviors and to identify related factors in the aspects of demographic factors, health status and cancer risk recognition, attitude to cancer screening, health behaviors, and inhibiting or facilitating factors to stomach cancer screening in an urban area. Data was collected through self-administered questionnaires from 403 people aged 40 to 69 years from April 23th to May 15th, 2002. Practice behaviors were classified as : "ever" or "never", and "repeat" or "not repeat" grouped based on a recent 5 year screening history. The results were as follows: 1. Among the 403 subjects: "the ever group" was 23.8% and "the repeat group" was 4.0%, The rates of screening were 20.5% for men, 27.8% for those women, and 27.3% for aged 40-49, 24.5% for those aged 50-59, 19.0% for those aged 60-69. The rates of repeat screening were 4.0% for men, 4.1% for women, and 2.9% for those aged 40-49, 6.3% for aged 50-59, 2.5% for those aged 60-69. 2. The main factors associated with adherence to gastric cancer screening were education(post high school vs below : OR=2.44), previous cancer screening(yes vs no : OR=2.61), belief in personal health(no vs yes : OR=2.72), health status(unhealthy vs healthy : OR=3.40), possibility of cancer compared to others(low vs not low : OR=2.56), and regular exercise(yes vs no : OR=2.94). The main factor associated with adherence to gastric cancer repeat screening was other cancer screening(yes vs no : OR=6.33). Consequently, there is a need to change the recognition of the importance and necessity of stomach cancer screening in healthy conditions through health education, and to perform multiple screening tests each visit.

노인의료문제의 한국적 측면 (Korean Aspect of the Medical Problems of the Aged)

  • 권굉보;정종학
    • Journal of Yeungnam Medical Science
    • /
    • 제2권1호
    • /
    • pp.191-202
    • /
    • 1985
  • 우리 나라에서는 과거 20년간 경제사정이 호전되고 과학기술이 발달됨에 따라 국민 평균수명이 크게 연장 되였으며, 따라서 노인인구도 증가하게 되었다. 이와 같은 인구분포의 변화로 야기되는 여러 가지 문제중, 노령인구의 보건의학적인 현실성을 고찰하였다. 한국의 65세 이상 노인인구는 162만명으로 전체 인구의 4.0%를 차지하여 과거에 비하여 빨리 증가하였으나 8.9%, 10.3%, 15.8%의 일본, 미국 및 영국에 비해서는 아직 훨씬 낮은 편이다. 65세 이상 노인들의 25% 이상에서 진료를 요하는 높은 질환율을 나타내었으며, 질병별로는 순환기계질환 30.9%, 호흡기계질환 17.1%, 소화기계질환 8.6%, 정신장애 8.4%, 악성신생물 7.0% 등의 순이었다. 의료수혜 현황으로는 의료보호와 의료보험을 합하여 51%의 노인인구가 전액 혹은 일부 의료비 보조혜택을 받을 수 있으나 보험수혜노인의 수진율은 극히 낮아(1981년에 2.0%) 노인들의 진료 기피의 한국적 특색을 보여주고 있다. 노인들에 많은 성인병들은 만성진행형이어서 조기진단, 전문적관리 및 장기진료가 필요하나, 노인전문 진료기관, 장기수용시설 및 전문인력은 전무한 실정이다. 급속히 증가하는 노인인구의 보건을 위하여 양로시설과 장애노인수용소의 조속한 확충과 가정방문 간호원제도, 노인의료수혜 확장, 무료 신체검사, 성인병 예방운동 등 정부차원의 제도적 개선과 적극적 지원이 지금부터라도 시행되어야 되겠다.

  • PDF

설암의 술전 조직표본에서 악성도와 혈관내피세포성장인자 발현과의 상관관계 (CORRELATION BETWEEN VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND MALIGNANCY GRADING IN BIOPSY SPECIMENS OF TONGUE CANCERS)

  • 변준호;박봉욱;정인교;김종렬;김욱규;박봉수;김규천
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제27권6호
    • /
    • pp.528-534
    • /
    • 2005
  • Angiogenesis is important for the growth and metastasis of solid tumors. Some growth factors, inflammatory cytokines, and angiogenin are known to promote tumor angiogenesis. Among them, Vascular endothelial growth factor (VEGF) is the most intriguing factor in regard to tumor angiogenesis. Inhibition of VEGF activity by neutralizing antibodies or by the introduction of dominant negative VEGF receptors into endothelial cells of tumor-associated blood vessels resulted in the inhibition of tumor growth and in tumor regression, indicating that VEGF is a major initiator of tumor angiogenesis. VEGF promotes angiogenesis through their receptors, Flt-1 and Flk-1/KDR. on vascular endothelial cells. These two receptors were usually believed to be expressed specifically on vascular endothelial cell. Several reports have now shown that VEGF is not only significantly associated with microvessel density but also has prognostic value in both node-negative and node-positive oral squamous cell carcinoma. For many years several histologic features of the neoplasms are being considered when assessing the influence of malignancy grading on recurrence and prognosis. Among the characteristics investigated, degree of keratinization, nuclear pleomorphism, mode of invasion, microscopic depth of invasion, intravascular invasion, lymphocyte infiltration, and number of mitoses have been considered as important prognostic factors. So, this study was conducted to evaluate the correlation of vascular endothelial growth factor expression with malignancy in paraffin-embedded biopsy specimens from 11 patients with tongue cancers. Our results showed that high immunoreactivity specimens of VEGF expression were significantly lower keratinization degree and more pronounced nuclear pleomorphism than in low immunoreactivity specimens. Thus, VEGF expression could be used as a prognostic marker in tongue cancer.

성인에서 발생한 종격동 림프관종 3례 (Mediastinal Lymphangioma in Adults : Three Case Reports)

  • 김경찬;고원중;권오정;이병훈;황정혜;강은해;서지영;정만표;김호중;한정호;고영혜;김진국;김태성;이경수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제55권3호
    • /
    • pp.303-310
    • /
    • 2003
  • 종격종 림프관종은 림프관에서 기원하는 드문 양성 종양이다. 대부분 출생 시 존재하며 생후 첫 2년 이내 발견되는데, 성인에서는 매우 드물게 발생하며, 대부분 증상이 없이 단순 흉부 방사선촬영에서 이상소견이 발견되어 진단된다. 저자들은 단순 흉부 방사선촬영에서 이상소견이 발견된 3명의 환자에서 수술을 통하여 조직학적으로 종격동 림프관종임을 진단하고 치료한 3명의 환자를 경험하여 이를 보고하는 바이다.

암 등록사업의 현황과 추진방향 (Cancer Registration in Korea: The Present and Furtherance)

  • 안윤옥
    • Journal of Preventive Medicine and Public Health
    • /
    • 제40권4호
    • /
    • pp.265-272
    • /
    • 2007
  • It was not until 1975 that cancer registration was initiated in Korea; voluntary registration of cancer patients of training hospitals throughout the country began under the auspices of the Korean Cancer Society(KCS). However, an official cancer registration, the Korea Central Cancer Registry(KCCR), began on July 1st, 1980. Forty-five training and two non-training hospitals throughout the country initiated registration of patients in whom neoplasms had been found. Data related to case information specified are to be sent to the KCCR at the National Medical Center(it moved at National Cancer Center in 2000). The initial cancer registration of KCS was merged to the KCCR in 1980. Although the KCCR covers most all the large training hospitals in Korea, it cannot provide incidence data. It is, however, the only of its kind in the world, being neither hospital nor population based. The first population based cancer registry(PBCR) was launched in a small county, Kangwha(it has around 80,000 inhabitants), by Yonsei University Medical College in 1983. All data were collected by active methods, and incidence statistics for 1986-1992 appeared in Vol VII of the CI5. Another PBCR, Seoul Cancer Registry(SCR), started in 1991. It was supported by a civilian foundation, the Korean Foundation for Cancer Research. The basic idea of case registration of SCR was the incorporation of KCCR data to PBCR, e. g. dual sources of case registration, i.e., from the KCCR and also including cases diagnosed in small hospitals and other medical facilities. Assessing completeness and validity of case registration of SCR, the program and methodology used by the SCR was later extended to other large cities and areas in Korea, and the PBCR in each area was established. Cancer incidence statistics of Seoul for 1993-1997, Busan for 1996-1997, and Daegu for 1997-1998, as well as Kangwha for 1993-1997, appeared eventually in Vol VIII of the CI5. The Korean or 'pillar' model for a PBCR is a new one. The KCCR data file is a reliable basis, as a pillar, for a PBCR in each area. The main framework of the model for such a registry is the incorporation of a KCCR data file with data from additionally surveyed cases; the data related to cancer deaths, medical insurance claims, and visit-and surveillance of non-KCCR medical facilities. Cancer registration has been adopted as a national cancer control program by Korean government in 2004 as the Anti-Cancer Act was enacted. Since then, some officers have tried to launch a nation-wide PBCR covering whole country. In the meantime, however, cancer registration was interrupted and discontinued for years due to the Privacy Protection Law, which was solved by an amendment of the Anti-Cancer Act in 2006. It would be premature to establish the nation-wide PBCR in Korea. Instead, continuous efforts to improve the completeness of registration of the KCCR, to progress existing PBCRs, and to expand PBCRs over other areas are still to be devoted. The nation-wide PBCR in Korea will be established eventually with summation of the PBCRs of the Korean model.

Human Immunodeficiency Virus-1 Tat 단백에 의한 인간 CD99유전자의 조절기전에 대한 연구 (Human Immunodeficiency Virus-l Tat Positively Regulates the Human CD99 Gene via DNA Demethylation)

  • 이유진;김예리;이미경;이임순
    • 미생물학회지
    • /
    • 제44권4호
    • /
    • pp.277-281
    • /
    • 2008
  • HIV에 감염된 환자의 경우 다양한 종류의 암이 발생하는 것으로 알려져 있다. 이러한 암종의 높은 발생률의 원인으로, 감염에 의한 면역세포의 감소 및 결핍과 같은 간접적인 이유 뿐 아니라, HIV 바이러스 단백질의 발현이 직접적으로 병의 발생에 관여한다는 보고가 있다. 본 연구에서는 HIV 환자에서 높게 나타나는 암의 발생에 대한 기전을 이해하기 위하여 HIV-1 Tat 유전자와, 다수의 암 발생과 관련이 있는 세포막단백 CD99와의 관계를 규명하였다. 먼저 CD99의 발현에 미치는 Tat의 영향을 알아보기 위하여 HIV-1 Tat 발현 안정화 세포주를 확립하고 Tat 단백에 의한 CD99 유전자의 발현 양상 변화를 분석하였다. 실험결과 Tat의 발현에 의하여 CD99 유전자의 발현이 활성화되는 것이 관찰되었으며 이와 반대로 STAT3의 발현은 낮아졌다. CD99 프로모터는 CpG 함량이 높기 때문에 Tat 단백이 DNA 메칠화를 통해서 CD99 유전자의 발현을 조절하는지 확인하기 위하여 methylation specific PCR을 수행하였고 Tat의 발현이 높은 곳에서 특이적으로 CD99 프로모터 부위가 탈메칠화되는 것을 발견하였다. Tat 발현 세포에서만 특이적인 발현 차이를 보이는 유전자 분석을 위한 Differentially Expressed Gene keratin 17과 collagen, type IV 증가됨이 확인되었다. 위의 결과는 HIV Tat 단백이 직접 세포 단백들을 조절하여 암을 발생시킬 수 있다는 보고를 뒷받침한다.

악성 흉선종으로 오인된 결핵성 심낭농양 1예 (A Case of Tuberculous Pericardial Abscess Mimicking Thymic Carcinoma)

  • 박지영;박승아;안영환;장길수;김소연;안정선;홍은영;임수영;김건일;서진원;박성훈
    • Tuberculosis and Respiratory Diseases
    • /
    • 제70권4호
    • /
    • pp.347-351
    • /
    • 2011
  • We report here an unusual case of pericardial tuberculoma that was misdiagnosed as thymic carcinoma on an imaging study. A 48-year-old woman was referred for evaluation of an anterior mediastinal mass. Computed tomography (CT) scans of the chest displayed cystic masses mimicking thymic carcinoma at the anterior mediastinum. Pericardiotomy and surgical drainage of the cystic masses were done, and pathologic examination of the excised pericardial specimen showed a chronic granulomatous inflammation with necrosis, compatible with tuberculosis. Acid-fast bacilli were also identified in the specimen. After treatment with anti-tuberculosis drugs and steroids, the patient showed clinical improvement. Although tuberculous pericarditis usually presents as pericardial effusion or constrictive pericarditis, it can also present as a pericardial mass mimicking thymic carcinoma on CT. Therefore, we suggest that tuberculous pericardial abscess should be included in the differential diagnosis of a mediastinal mass in Korea, with intermediate tuberculosis prevalence.